Optimal Vaccine Subsidies for Endemic and Epidemic Diseases
Author
Abstract
Suggested Citation
Download full text from publisher
Other versions of this item:
- Matthew Goodkin-Gold & Michael Kremer & Christopher M. Snyder & Heidi L. Williams, 2020. "Optimal Vaccine Subsidies for Endemic and Epidemic Diseases," NBER Working Papers 28085, National Bureau of Economic Research, Inc.
References listed on IDEAS
- Caitlin E Kennedy & Ping Teresa Yeh & Kaitlyn Atkins & Virginia A Fonner & Michael D Sweat & Kevin R O’Reilly & George W Rutherford & Rachel Baggaley & Julia Samuelson, 2020. "Economic compensation interventions to increase uptake of voluntary medical male circumcision for HIV prevention: A systematic review and meta-analysis," PLOS ONE, Public Library of Science, vol. 15(1), pages 1-15, January.
- Charles F. Manski, 2017. "Mandating vaccination with unknown indirect effects," Journal of Public Economic Theory, Association for Public Economic Theory, vol. 19(3), pages 603-619, June.
- Michael Kremer & Christopher M. Snyder, 2018.
"Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals,"
Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 53(1), pages 235-273, August.
- Michael Kremer & Christopher M. Snyder, 2018. "Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals," NBER Working Papers 24206, National Bureau of Economic Research, Inc.
- Andrea Galeotti & Brian W. Rogers, 2013.
"Strategic Immunization and Group Structure,"
American Economic Journal: Microeconomics, American Economic Association, vol. 5(2), pages 1-32, May.
- Andrea Galeotti & Brian Rogers, 2012. "Strategic Immunization and Group Structure," Discussion Papers 1551, Northwestern University, Center for Mathematical Studies in Economics and Management Science.
- Galeotti, Andrea & W. Rogers, Brian, 2012. "Strategic immunization and group structure," ISER Working Paper Series 2012-16, Institute for Social and Economic Research.
- Michael Kremer, 1996. "Integrating Behavioral Choice into Epidemiological Models of AIDS," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 111(2), pages 549-573.
- Korinek, Anton & Bethune, Zachary, 2020.
"COVID-19 Infection Externalities: Trading Off Lives vs. Livelihoods,"
CEPR Discussion Papers
14596, C.E.P.R. Discussion Papers.
- Zachary A. Bethune & Anton Korinek, 2020. "Covid-19 Infection Externalities: Trading Off Lives vs. Livelihoods," NBER Working Papers 27009, National Bureau of Economic Research, Inc.
- Michael Kremer & Christopher M. Snyder, 2015.
"Preventives Versus Treatments,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 130(3), pages 1167-1239.
- Michael Kremer & Christopher Snyder, 2015. "Preventives Versus Treatments," NBER Working Papers 21012, National Bureau of Economic Research, Inc.
- Enayati, Shakiba & Özaltın, Osman Y., 2020. "Optimal influenza vaccine distribution with equity," European Journal of Operational Research, Elsevier, vol. 283(2), pages 714-725.
- Francis, Peter J., 1997. "Dynamic epidemiology and the market for vaccinations," Journal of Public Economics, Elsevier, vol. 63(3), pages 383-406, February.
- Chantal Nguyen & Jean M Carlson, 2016. "Optimizing Real-Time Vaccine Allocation in a Stochastic SIR Model," PLOS ONE, Public Library of Science, vol. 11(4), pages 1-27, April.
- Stéphane Mechoulan, 2007.
"Market structure and communicable diseases,"
Canadian Journal of Economics/Revue canadienne d'économique, John Wiley & Sons, vol. 40(2), pages 468-492, May.
- Stéphane Mechoulan, 2007. "Market structure and communicable diseases," Canadian Journal of Economics, Canadian Economics Association, vol. 40(2), pages 468-492, May.
- Stéphane Mechoulan, 2005. "Market Structure and Communicable Diseases," Working Papers tecipa-241, University of Toronto, Department of Economics.
- Kremer, Michael & Snyder, Christopher, 2018. "Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global D," CEPR Discussion Papers 12751, C.E.P.R. Discussion Papers.
- Avner Ahituv & V. Joseph Hotz & Tomas Philipson, 1996. "The Responsiveness of the Demand for Condoms to the Local Prevalence of AIDS," Journal of Human Resources, University of Wisconsin Press, vol. 31(4), pages 869-897.
- Joseph Cook & Marc Jeuland & Brian Maskery & Donald Lauria & Dipika Sur & John Clemens & Dale Whittington, 2009. "Using private demand studies to calculate socially optimal vaccine subsidies in developing countries," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 28(1), pages 6-28.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Seth M. Freedman & Daniel W. Sacks & Kosali I. Simon & Coady Wing, 2022. "Direct and indirect effects of vaccines: Evidence from COVID-19," NBER Working Papers 30550, National Bureau of Economic Research, Inc.
- Joshua S. Gans, 2023.
"Vaccine Hesitancy, Passports, And The Demand For Vaccination,"
International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, vol. 64(2), pages 641-652, May.
- Joshua S. Gans, 2021. "Vaccine Hesitancy, Passports and the Demand for Vaccination," NBER Working Papers 29075, National Bureau of Economic Research, Inc.
- Brian C. Albrecht & Shruti Rajagopalan, 2023. "Inframarginal externalities: COVID-19, vaccines, and universal mandates," Public Choice, Springer, vol. 195(1), pages 55-72, April.
- Kazunobu Hayakawa, 2022. "Impacts of Vaccination on International Trade During the Pandemic Era," The Developing Economies, Institute of Developing Economies, vol. 60(4), pages 206-227, December.
- Daoping Wang & Ottar N. Bjørnstad & Tianyang Lei & Yida Sun & Jingwen Huo & Qi Hao & Zhao Zeng & Shupeng Zhu & Stéphane Hallegatte & Ruiyun Li & Dabo Guan & Nils C. Stenseth, 2023. "Supply chains create global benefits from improved vaccine accessibility," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
- Wang, Jingrui & Zhang, Huizhen & Jin, Xing & Ma, Leyu & Chen, Yueren & Wang, Chao & Zhao, Jian & An, Tianbo, 2023. "Subsidy policy with punishment mechanism can promote voluntary vaccination behaviors in structured populations," Chaos, Solitons & Fractals, Elsevier, vol. 174(C).
- Boppart, Timo & Harmenberg, Karl & Krusell, Per & Olsson, Jonna, 2022. "Integrated epi-econ assessment of vaccination," Journal of Economic Dynamics and Control, Elsevier, vol. 140(C).
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Kremer, Michael & Williams, Heidi & Snyder, Christopher & Goodkin-Gold, Matthew, 2020. "Optimal Subsidies for Prevention of Infectious Disease," CEPR Discussion Papers 15433, C.E.P.R. Discussion Papers.
- Goodkin-Gold, Matthew & Kremer, Michael & Snyder, Christopher M. & Williams, Heidi, 2022. "Optimal vaccine subsidies for endemic diseases," International Journal of Industrial Organization, Elsevier, vol. 84(C).
- David E. Bloom & Michael Kuhn & Klaus Prettner, 2022.
"Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses,"
Journal of Economic Literature, American Economic Association, vol. 60(1), pages 85-131, March.
- David E. Bloom & Michael Kuhn & Klaus Prettner, 2020. "Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses," NBER Working Papers 27757, National Bureau of Economic Research, Inc.
- Bloom, David & Kuhn, Michael & Prettner, Klaus, 2021. "Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses," CEPR Discussion Papers 15997, C.E.P.R. Discussion Papers.
- David E. Bloom & Michael Kuhn & Klaus Prettner, 2020. "Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses," Working Papers 2020-17, The George Washington University, Institute for International Economic Policy.
- Bloom, David E. & Kuhn, Michael & Prettner, Klaus, 2020. "Modern Infectious Diseases: Macroeconomic Impacts and Policy Responses," IZA Discussion Papers 13625, Institute of Labor Economics (IZA).
- Toxvaerd, Flavio, 2010. "Recurrent Infection and Externalities in Prevention," CEPR Discussion Papers 8112, C.E.P.R. Discussion Papers.
- Goyal, Sanjeev & Vigier, Adrien, 2015.
"Interaction, protection and epidemics,"
Journal of Public Economics, Elsevier, vol. 125(C), pages 64-69.
- Sanjeev Goyal & Adrien Vigier, 2014. "Interaction, Protection and Epidemics," Cambridge Working Papers in Economics 1458, Faculty of Economics, University of Cambridge.
- Schankerman, Mark & Galasso, Alberto, 2020. "Licensing Life-Saving Drugs for Developing Countries: Evidence from the Medicines Patent Pool," CEPR Discussion Papers 15544, C.E.P.R. Discussion Papers.
- Christopher M. Snyder & Victor J. Tremblay, 2018. "Introduction to the Special Issue on “The Intersection Between Industrial Organization and Healthcare Economics”," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 53(1), pages 1-6, August.
- Cerdeiro, Diego A., 2017.
"Contagion exposure and protection technology,"
Games and Economic Behavior, Elsevier, vol. 105(C), pages 230-254.
- Diego Cerdeiro, 2015. "Contagion Exposure and Protection Technology," Cambridge Working Papers in Economics 1557, Faculty of Economics, University of Cambridge.
- Luca Gori & Cristiana Mammana & Piero Manfredi & Elisabetta Michetti, 2022. "Economic development with deadly communicable diseases and public prevention," Journal of Public Economic Theory, Association for Public Economic Theory, vol. 24(5), pages 912-943, October.
- Talamàs, Eduard & Vohra, Rakesh, 2020. "Free and perfectly safe but only partially effective vaccines can harm everyone," Games and Economic Behavior, Elsevier, vol. 122(C), pages 277-289.
- d’Albis, Hippolyte & Augeraud-Véron, Emmanuelle, 2021.
"Optimal prevention and elimination of infectious diseases,"
Journal of Mathematical Economics, Elsevier, vol. 93(C).
- Hippolyte d'Albis & Emmanuelle Augeraud-Véron, 2021. "Optimal prevention and elimination of infectious diseases," Post-Print halshs-03166714, HAL.
- Hippolyte d'Albis & Emmanuelle Augeraud-Véron, 2021. "Optimal Prevention and Elimination of Infectious Diseases," PSE Working Papers halshs-02563356, HAL.
- Hippolyte d'Albis & Emmanuelle Augeraud-Véron, 2021. "Optimal prevention and elimination of infectious diseases," PSE-Ecole d'économie de Paris (Postprint) halshs-03166714, HAL.
- Hippolyte d'Albis & Emmanuelle Augeraud-Véron, 2021. "Optimal Prevention and Elimination of Infectious Diseases," Working Papers halshs-02563356, HAL.
- Sander Heinsalu, 2020. "Infection arbitrage," Papers 2004.08701, arXiv.org, revised Apr 2020.
- Mark Gersovitz & Jeffrey S. Hammer, 2004.
"The Economical Control of Infectious Diseases,"
Economic Journal, Royal Economic Society, vol. 114(492), pages 1-27, January.
- Gersovitz, Mark & Hammer, Jeffrey S., 2001. "The economic control of infectious diseases," Policy Research Working Paper Series 2607, The World Bank.
- Michael Kremer & Christopher M. Snyder, 2018.
"Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals,"
Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 53(1), pages 235-273, August.
- Michael Kremer & Christopher M. Snyder, 2018. "Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals," NBER Working Papers 24206, National Bureau of Economic Research, Inc.
- Timo Boppart & Karl Harmenberg & John Hassler & Per Krusell & Jonna Olsson, 2020.
"Integrated Epi-Econ Assessment,"
NBER Working Papers
28282, National Bureau of Economic Research, Inc.
- Timo Boppart & Karl Harmenberg & John Hassler & Per Krusell & Jonna Olsson, 2020. "Integrated epi-econ assessment," Edinburgh School of Economics Discussion Paper Series 297, Edinburgh School of Economics, University of Edinburgh.
- Boppart, Timo & Harmenberg, Karl & Hassler, John & Krusell, Per & Olsson, Jonna, 2020. "Integrated epi-econ assessment," CEPR Discussion Papers 15595, C.E.P.R. Discussion Papers.
- Bradley, Jake & Ruggieri, Alessandro & Spencer, Adam Hal, 2021.
"Twin Peaks: Covid-19 and the labor market,"
European Economic Review, Elsevier, vol. 138(C).
- Jake Bradley & Alessandro Ruggieri & Adam Spencer, 2020. "Twin peaks: COVID-19 and the labour market," Discussion Papers 2020/06, University of Nottingham, Centre for Finance, Credit and Macroeconomics (CFCM).
- Francis, Andrew M. & Mialon, Hugo M., 2010. "Tolerance and HIV," Journal of Health Economics, Elsevier, vol. 29(2), pages 250-267, March.
- Eswaran, Mukesh & Gallini, Nancy, 2017.
"Can Competition Extend the Golden Age of Antibiotics?,"
Microeconomics.ca working papers
-2017-9, Vancouver School of Economics, revised 19 Oct 2017.
- Eswaran, Mukesh & Gallini, Nancy, 2018. "Can Competition Extend the Golden Age of Antibiotics?," Microeconomics.ca working papers tina_marandola-2018-1, Vancouver School of Economics, revised 29 Jan 2018.
- Jelnov, Artyom & Jelnov, Pavel, 2022.
"Vaccination policy and trust,"
Economic Modelling, Elsevier, vol. 108(C).
- Jelnov, Artyom & Jelnov, Pavel, 2021. "Vaccination Policy and Trust," GLO Discussion Paper Series 1003, Global Labor Organization (GLO).
- Jelnov, Artyom & Jelnov, Pavel, 2021. "Vaccination Policy and Trust," IZA Discussion Papers 14947, Institute of Labor Economics (IZA).
- Zachary S. Brown & Randall A. Kramer, 2018. "Preference Heterogeneity in the Structural Estimation of Efficient Pigovian Incentives for Insecticide Spraying to Reduce Malaria," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 70(1), pages 169-190, May.
More about this item
JEL classification:
- D4 - Microeconomics - - Market Structure, Pricing, and Design
- I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
- L11 - Industrial Organization - - Market Structure, Firm Strategy, and Market Performance - - - Production, Pricing, and Market Structure; Size Distribution of Firms
- L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology; Plastics
- O31 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Innovation and Invention: Processes and Incentives
NEP fields
This paper has been announced in the following NEP Reports:- NEP-COM-2021-02-22 (Industrial Competition)
- NEP-DEM-2021-02-22 (Demographic Economics)
- NEP-HEA-2021-02-22 (Health Economics)
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bfi:wpaper:2020-162. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Toni Shears (email available below). General contact details of provider: https://edirc.repec.org/data/mfichus.html .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.